WallStreetZenWallStreetZen

NASDAQ: IPSC
Century Therapeutics Inc Stock Ownership - Who owns Century Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Century Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Douglas CarrSVP Finance Operations2026-02-03323$1.82
$588.51Sell
Chad CowanChief Scientific Officer2026-01-021,611$1.00
$1.60kSell
Chad CowanChief Scientific Officer2025-12-2258,060$0.85
$49.23kBuy
Brent PfeiffenbergerPresident and CEO2025-12-1252,000$0.58
$30.37kBuy
Brent PfeiffenbergerPresident and CEO2025-12-10463$0.53
$243.54Sell
Douglas CarrSVP Finance Operations2025-12-08257$0.53
$136.72Sell
Gregory RussottiTitle Chief Technology and Manufacturing Officer2025-12-08526$0.53
$279.83Sell
Chad CowanChief Scientific Officer2025-11-205,462$0.50
$2.74kSell
Brent PfeiffenbergerPresident and CEO2025-11-1935,000$0.50
$17.33kBuy
Brent PfeiffenbergerPresident and CEO2025-11-1732,456$0.45
$14.74kSell

1 of 3

IPSC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IPSC insiders and whales buy or sell their stock.

IPSC Shareholders

What type of owners hold Century Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aktiengesellschaft Bayer14.52%12,675,838$22.18MInsider
Versant Venture Capital VI LP13.93%12,166,109$21.29MInsider
Fujifilm Cellular Dynamics Inc7.97%6,955,207$12.17MInsider
Brent Pfeiffenberger4.35%3,797,990$6.65MInsider
Eli Casdin3.67%3,206,380$5.61MInsider
Vanguard Group Inc2.41%2,103,869$3.68MInstitution
Spruce Street Capital LP1.63%1,421,532$2.49MInstitution
Renaissance Technologies LLC1.55%1,349,200$2.36MInstitution
Acadian Asset Management LLC1.39%1,217,103$2.13MInstitution
Syncona Portfolio Ltd1.39%1,213,056$2.12MInstitution

1 of 3

IPSC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPSC10.63%48.71%Net BuyingNet Buying
MSLE0.00%0.00%
SGMT27.95%66.73%Net SellingNet Selling
EDIT39.31%33.76%Net SellingNet Selling
ZNTL30.39%42.88%Net SellingNet Selling
View Top Biotech Stocks

Century Therapeutics Stock Ownership FAQ

Who owns Century Therapeutics?

Century Therapeutics (NASDAQ: IPSC) is owned by 10.63% institutional shareholders, 48.71% Century Therapeutics insiders, and 40.66% retail investors. Aktiengesellschaft Bayer is the largest individual Century Therapeutics shareholder, owning 12.68M shares representing 14.52% of the company. Aktiengesellschaft Bayer's Century Therapeutics shares are currently valued at $24.46M.

If you're new to stock investing, here's how to buy Century Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.